Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-03-2009 | Editorial Commentary

Hybrid PET-dynamic CECT in the management of breast cancer

Authors: Rakesh Kumar, Chandan Jyoti Das

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 3/2009

Excerpt

Breast cancer is the most common cancer and second commonest cause of cancer death after lung and bronchial cancer in women. In Europe, 429,900 cases of breast cancer were diagnosed in 2006 and 131,900 women died from breast cancer in the same year [1]. It has been estimated that 182,460 new cases of breast cancer will have been diagnosed and 71,030 patients will have died from breast cancer in United States in 2008 [2]. Early diagnosis and reliable imaging assessment of response to treatment are essential in the clinical management of breast cancer. Conventional imaging modalities such as screen-film mammography, digital mammography, ultrasonography (USG), and magnetic resonance imaging (MRI), provide only morphological details and do not provide information on the metabolic status of a lesion, which is very important in differentiating a benign from a malignant lesion, and therefore conventional imaging modalities lack specificity. …

Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581–92.PubMedCrossRef

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics 2008 CA. Cancer J Clin 2008;58:71–96.CrossRef

Cermik TF, Mavi A, Basu S, Alavi A. Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer. Eur J Nucl Med Mol Imaging 2008;35:475–83.PubMedCrossRef

Belohlavek O. What is the role of FDG-PET in the initial staging of breast cancer. Eur J Nucl Med Mol Imaging 2008;35:472–4.PubMedCrossRef

Basu S, Mavi A, Cermik T, Houseni M, Alavi A. Implications of standardized uptake value measurements of the primary lesions in proven cases of breast carcinoma with different degree of disease burden at diagnosis: does 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography predict tumor biology? Mol Imaging Biol 2008;10:62–6.PubMedCrossRef

Kumar R, Loving V, Chauhan A, Zhuang H, Alavi A. Dual time point imaging and its potential to improve breast cancer diagnosis with F18-fluorodeoxyglucose positron emission tomography. J Nucl Med 2005;46:1819–24.PubMed

Kumar R, Chauhan A, Zhuang H, Chandra P, Schnall M, et al. Standardized uptake values of normal breast tissue with 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography: variations with age, breast density, and menopausal status. Mol Imaging Biol 2006;8:355–62.PubMedCrossRef

Kumar R, Chauhan A, Zhuang H, Chandra P, Alavi A. Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer. Breast Cancer Res Treat 2006;98:267–74.PubMedCrossRef

Zhang J, Wang R, Lou H, Zou Y, Zhang M. Functional computed tomographic quantification of angiogenesis in rabbit VX2 soft-tissue tumour before and after interventional therapy. J Comput Assist Tomogr 2008;32:697–705.PubMedCrossRef

10.

Miles KA. Perfusion imaging with computed tomography: brain and beyond. Eur Radiol 2006;16(Suppl 7):M37–M43.PubMed

11.

Akashi-Tanaka S, Shien T, Tsukagoshi S, Funabasama S, Miyagawa K, Terada K, et al. Whole-breast volume perfusion images using 256-row multislice computed tomography: visualization of lesions with ductal spread. Breast Cancer 2009;16:62–7.PubMedCrossRef

12.

Ma SH, Le HB, Jia BH, Wang ZX, Xiao ZW, Cheng XL, et al. Peripheral pulmonary nodules: relationship between multi-slice spiral CT perfusion imaging and tumour angiogenesis and VEGF expression. BMC Cancer 2008;8:186.PubMedCrossRef

13.

Goh V, Halligan S, Wellsted DM, Bartram CI. Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study. Eur Radiol 2008. doi:10.1007/s00330-008-1128-1.

14.

Ippolito D, Sironi S, Pozzi M, Antolini L, Ratti L, Alberzoni C, et al. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumour vascularization. Acad Radiol 2008;15:919–27.PubMedCrossRef

15.

Zhou Z, Wu J, Han M, Liu R, Chen Z, Huang H, et al. MSCT perfusion analysis of nasopharyngeal cancer. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2008;22:150–2.PubMed

16.

Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Schubert EK, Tseng J, et al. Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. J Nucl Med 2003;44:1806–14.PubMed

17.

Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Charlop A, Lawton TJ, et al. Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. J Nucl Med 2002;43:500–9.PubMed

18.

Hentschel M, Paulus T, Mix M, Moser E, Nitzsche EU, Brink I. Analysis of blood flow and glucose metabolism in mammary carcinomas and normal breast: a H2(15)O PET and 18F-FDG PET study. Nucl Med Commun 2007;28:789–97.PubMedCrossRef

19.

Groves AM, Wishart GC, Shastry M, Moyle P, Iddles S, Britton P, et al. Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CT. Eur J Nucl Med Mol Imaging 2008. doi:10.1007/s00259-008-0948-1.

20.

Miles KA, Griffiths MR, Keith CJ. Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography. Eur J Nucl Med Mol Imaging 2006;33:22–8.PubMedCrossRef

21.

Bisdas S, Spicer K, Rumboldt Z. Whole-tumour perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positron-emission tomography/CT imaging. AJNR Am J Neuroradiol 2008;29:1376–81.PubMedCrossRef

22.

Hayes C, Padhani AR, Leach MO. Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 2002;15:154–63.PubMedCrossRef

23.

Semple SI, Gilbert FJ, Redpath TW, Staff RT, Ahearn TS, Welch AE, et al. The relationship between vascular and metabolic characteristics of primary breast tumours. Eur Radiol 2004;14:2038–45.PubMedCrossRef

24.

Brix G, Henze M, Knopp MV, Lucht R, Doll J, Junkermann H, et al. Comparison of pharmacokinetic MRI and [18F] fluorodeoxyglucose PET in the diagnosis of breast cancer: initial experience. Eur Radiol 2001;11:2058–70.PubMedCrossRef

Title: Hybrid PET-dynamic CECT in the management of breast cancer
Authors: Rakesh Kumar
Chandan Jyoti Das
Publication date: 01-03-2009
Publisher: Springer-Verlag
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 3/2009
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-008-1055-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Hybrid PET-dynamic CECT in the management of breast cancer

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2009

Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET

Syllabus for postgraduate specialisation in Nuclear Medicine

Is the lung scan alive and well? Facts and controversies in defining the role of lung scintigraphy for the diagnosis of pulmonary embolism in the era of MDCT

Noninvasive functional imaging of P-glycoprotein-mediated doxorubicin resistance in a mouse model of hereditary breast cancer to predict response, and assign P-gp inhibitor sensitivity

Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT

Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study